Reaction
Vulval Disorder reporting signals
As of the last recalculation, Vulval Disorder appears in 655 FAERS reports alongside 12 co-occurring drug terms. The strongest observed disproportionality signal is MICONAZOLE NITRATE (PRR 44.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Miconazole Nitrate | 12 | 44.5 | 44.5 |
| Temozolomide | 27 | 42.4 | 42.5 |
| Adalimumab-Fkjp | 56 | 41.9 | 42.0 |
| Adalimumab-Aaty | 56 | 41.0 | 41.1 |
| Adalimumab-Adaz | 57 | 37.5 | 37.5 |
| Atovaquone | 8 | 32.0 | 32.0 |
| Ciclesonide | 13 | 30.9 | 31.0 |
| Octreotide Acetate | 28 | 30.3 | 30.3 |
| Etonogestrel And Ethinyl Estradiol | 16 | 23.5 | 23.5 |
| Tiotropium Bromide Inhalation Spray | 8 | 23.0 | 23.0 |
| Bendamustine Hydrochloride | 5 | 13.4 | 13.4 |
| Copper | 7 | 5.2 | 5.2 |